Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been found to have beneficial effects on inflammatory markers, metabolic dysregulation, and depressive symptoms.
The supplementation of both omega-3 and nanocurcumin could decrease the incidence and severity of episodic migraine by reducing the genetic expression of a particular molecule in the body, based on the findings of a two-month RCT.
